Goldman Sachs raised the firm’s price target on Braze (BRZE) to $52 from $50 and keeps a Buy rating on the shares after its Q2 earnings beat this week. The stock rose over 13% on Friday thanks to the 5% revenue upside in the quarter, culminating in organic revenue growth acceleration, 25% organic cRPO growth in the quarter, implying cRPO bookings acceleration, and a return to significant margin expansion for the year after meaningfully guiding below expectations last quarter, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRZE:
- Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
- BRZE Earnings: Braze Stock Soars on Q2 Beats, Guidance Update
- Braze, Inc. Reports Strong Q2 2026 Growth and Optimism
- 3 Best Stocks to Buy Now, 9/5/2025, According to Top Analysts
- Tesla’s big pay proposal for Musk, Wall Street sours on Lululemon: Morning Buzz